Grupo de Investigacion en Superficie Ocular (GSO)
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (6)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2015
-
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 3, pp. 361-368
-
Consensus document on allergic conjunctivitis (DECA)
Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 2, pp. 94-106
2014
-
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients
Rheumatology (Oxford, England), Vol. 53, Núm. 12, pp. 2223-2231